Skip to search formSkip to main contentSkip to account menu

moxifloxacin 5 MG/ML Ophthalmic Solution [Vigamox]

Known as: Vigamox 0.5 % Ophthalmic Solution, Vigamox 5 MG/ML Ophthalmic Solution, MOXIFLOXACIN HYDROCHLORIDE 5 mg in 1 mL OPHTHALMIC SOLUTION/ DROPS [VIGAMOX] 
National Institutes of Health

Related topics

Related topics

10 relations
Hydrochloric AcidMoxifloxacin hydrochlorideOphthalmic SolutionSodium Chloride

Broader (1)

moxifloxacin Ophthalmic Solution [Vigamox]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Surface modification of intraocular lenses towards controlled drug delivery
Purpose Ocular drug delivery systems replacing or complementing the usual therapeutics after cataract surgery have been the… 
Review
2010
Review
2010
Azithromycin review Azithromycin in ophthAlmology
  • 2010
  • Corpus ID: 51821633
this subject-masked, randomized, active and placebo-controlled study compared subjects’ perceptions of two antibiotic ophthalmic… 
2009
2009
Moxifloxacin intrakameral: Eine sichere Option zur Endophthalmitisprophylaxe?
ZusammenfassungHintergrundDie Wirksamkeit von Moxifloxacin (Vigamox®) umfasst die meisten für bakterielle Endophthalmitiden… 
2006
2006
Preservation of the Retinal Function Following a Single Intravitreal Injection of VIGAMOX ® Solution in Non–Human Primates
2006
2006
Vigamox® (0.5% Moxifloxacin) Is Effective in Reducing Staphylococcus aureus Colony Counts in a NZW Rabbit Endophthalmitis Model
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)